INBISTRA Partners with SDDN to Advance Early-Stage Drug Discovery in Spain
June 28, 2025
We are pleased to share that INBISTRA has joined the Spanish Drug Discovery Network (SDDN) as a Partner, strengthening our commitment to early-stage biotech innovation.
The SDDN is Spain's leading forum connecting academia and industry to drive excellence in drug discovery. Through its annual congress, working groups, and webinars, it fosters collaboration, knowledge exchange and cutting-edge solutions in preclinical research.
At INBISTRA, we help biotech and pharma companies build smarter, fundable R&D pipelines and make confident early-stage decisions — supported by our proprietary AI tools for target selection, disease positioning and competitive landscape mapping.
Becoming a Member of the SDDN reinforces our mission to collaborate, share know-how, and contribute to a robust Spanish innovation ecosystem.
🤝 We look forward to supporting SDDN's initiatives and engaging with fellow members at upcoming meetings and events!